research

Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL

Authors
Publication date
1 March 2008
Publisher
'American Society of Hematology'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      Last time updated on 04/12/2019
      Supporting member

      Queen Mary Research Online

      redirect
      oaioai:qmro.qmul.ac.uk:123456789/...
      Last time updated on 05/04/2016